The interaction of the cancer chemotherapeutic agent cis-diamminedichloroplatinum(II) (cis-DDP) with DNA appears essential to the action of the drug. The efficacy of the drug can be modulated by the capacity of a cell to repair the damaged DNA or to efficiently replicate on damaged templates. However, these systems are not infallible and toxicity and mutagenicity do result. I intend to investigate these phenomena in murine leukemia L1210 cells and in a cis-DDP resistant subline. DNA of both cell lines can be equally platinated, therefore, resistance appears to reflect a differential capacity of the cells to deal with the damage. Initial experiments will characterize the interaction of cis-DDP with DNA and then be extended to the formation and removal of cis-DDP lesions in L1210 cells. The enzymology of this repair process will be analyzed. Several approaches will be used to investigate the effect of lesions on DNA synthesis. These include an analysis of the size of newly synthesized DNA, its ligation and possible recombination. DNA of known base sequence will be used to determine sites of inhibition of replication. Mutagenesis in a whole cell system will be investigated specifically in the adenine phosphoribosyl transferase gene, an easily selectable mutant. It is proposed that resistance to cis-DDP may be mediated by a gene amplification process and an attempt will be made to isolate the gene and then the gene product(s) involved. The involvement of aberrant replication in the development of resistance will be assessed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Modified Research Career Development Award (K04)
Project #
5K04CA000906-05
Application #
3071502
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1983-08-01
Project End
1988-07-31
Budget Start
1987-08-01
Budget End
1988-07-31
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
Overall Medical
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Jennerwein, M M; Eastman, A; Khokhar, A (1989) Characterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexes. Chem Biol Interact 70:39-49
Sheibani, N; Jennerwein, M M; Eastman, A (1989) DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA. Biochemistry 28:3120-4
Sorenson, C M; Eastman, A (1988) Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. Cancer Res 48:6703-7
Eastman, A; Schulte, N (1988) Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). Biochemistry 27:4730-4
Eastman, A; Jennerwein, M M; Nagel, D L (1988) Characterization of bifunctional adducts produced in DNA by trans-diamminedichloroplatinum(II). Chem Biol Interact 67:71-80
Sorenson, C M; Eastman, A (1988) Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks. Cancer Res 48:4484-8
Eastman, A (1987) Glutathione-mediated activation of anticancer platinum(IV) complexes. Biochem Pharmacol 36:4177-8
Eastman, A (1987) Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes. Chem Biol Interact 61:241-8
Eastman, A; Barry, M A (1987) Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione. Biochemistry 26:3303-7
Richon, V M; Schulte, N; Eastman, A (1987) Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells. Cancer Res 47:2056-61

Showing the most recent 10 out of 14 publications